Iba Proton Therapy, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$136Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
113clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| James Metz | Philadelphia, PA | Radiation Oncology | $10,601.52 |
| Steven Frank | Houston, TX | Radiation Oncology | $9,290.86 |
| Jing Zeng | Seattle, WA | Radiation Oncology | $7,713.95 |
| Ramesh Rengan | Seattle, WA | Radiation Oncology | $7,664.33 |
| Peyman Kabolizadeh | Fountain Valley, CA | Radiation Oncology | $5,929.52 |
| Rohan Deraniyagala | Dearborn, MI | Radiation Oncology | $5,387.97 |
| Gary Gunn | Houston, TX | Radiation Oncology | $4,330.45 |
| Arie Dosoretz | Fort Myers, FL | Radiation Oncology | $3,898.67 |
| Jason Efstathiou | Boston, MA | Radiation Oncology | $3,885.96 |
| Charles Simone | New York, NY | Radiation Oncology | $3,809.09 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.